Serena Williams wants to be transparent and is opening up about her fitness journey, revealing she's taking a GLP-1 ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

Serena Williams revealed how she turned her health around with the help of a GLP-1 medication after she struggled to lose ...

According to the Cleaveland Clinic, GLP-1 agonists (glucagon-like peptide-1 receptor agonists) are injectable medications ...

Serena Williams reveals she has been using GLP-1 medications for weight loss, shedding 31 pounds. The tennis star highlights its benefits on her health.

Researchers have developed fluorescent probes, daLUXendins, to track dual agonist drugs like tirzepatide in live tissues. The ...

Serena Williams, the tennis legend with 23 Grand Slam singles titles, has always been admired for her athletic prowess and ...

Daytime TV has gone through many changes — including heartbreaking cancellations and surprising casting swaps — ahead of the ...

"This retrospective cohort study found that taking GLP-1RAs was associated with a reduced overall risk of cancer, including lower risks of endometrial, ovarian, and meningioma cancers, among patients ...

Discover a study exploring how GLP-1 receptor agonists may reduce symptoms of hidradenitis suppurativa through weight loss and anti-inflammatory effects.

Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using GLP-1s.

Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs ...